Mark C. Wiggins

EVP - Business Development, Biogen.

Companies

Zogenix (United States)Board member May 25, 2011 to Mar 9, 2022¹
Tracon Pharmaceuticals, Inc.Chief Business Officer May 30, 2018 to Feb 1, 2022²
BiogenEVP - Business Development Jan 5, 2006 to Sep 29, 2008³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Zogenix (United States)0 shares⁴Mar 7, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 7, 2022U 2,500 shares of Zogenix (United States)⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARZogenix (United States), Board member
2
SEC EDGARTracon Pharmaceuticals, Inc., Chief Business Officer
3
SEC EDGARBiogen, EVP - Business Development
4
SEC EDGARZogenix (United States) shares after the filing of Mar 7, 2022